| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | NB2E1YP49F |
| Parent Compound: | YOHIMBINE |
| InChI Key | PIPZGJSEDRMUAW-VJDCAHTMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H27ClN2O3 |
| Molecular Weight | 390.91 |
| AlogP | 2.65 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 65.56 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 26.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 16 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | 27 | - | 15 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 113 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Phobia, Social | 3 | D000072861 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
| Tobacco Use Disorder | 1 | D014029 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL537669 |
| EPA CompTox | DTXSID40891272 |
| FDA SRS | NB2E1YP49F |
| PubChem | 6169 |
| SureChEMBL | SCHEMBL33955 |